Following the resignation of Phil Parkes as WorkSafe Chief Executive and a looming proposal to cut up to 120 staff, Steve Haszard has taken up the top job WorkSafe New Zealand Board Chair Jennifer Kerr has announced the appointment of Steve Haszard as the organisation’s next Chief Executive. Continue →

WorkSafe New Zealand Board Chair Jennifer Kerr has announced the resignation of Chief Executive Phil Parkes “Phil has been a strong voice for the need to collectively prioritise health and safety,” says Kerr. Continue →

Bronwyn Presland has been appointed Executive Director of the Health and Safety Association of New Zealand (HASANZ), replacing Philip Aldridge on Monday 13 December HASANZ is the umbrella organisation for workplace health and safety professions in New Zealand and was established in September 2014 to raise professional standards to provide healthier and safer workplaces. Continue →

Mary Alice Simon has been appointed Chief Operating Officer (COO) at Helius Therapeutics – New Zealand’s largest licenced medicinal cannabis company Ms Simon joins Helius with extensive experience in the pharmaceuticals industry – both in Operations and Quality Assurance. Continue →

WorkSafe has appointed Karl Maddaford as National Manager Critical Response Mr Maddaford brings both national and international experience to the role, with a career including service with the United Nations and the New Zealand Defence Force, and more recently seconded by NZDF to the Pike River Recovery Agency. Continue →

The Chair of WorkSafe New Zealand, Ross Wilson announced today that following a publicly advertised selection process, Phil Parkes will be the agency’s new Chief Executive “Phil is currently WorkSafe’s Chief Operating Officer, leading our Operations Group of over 300 employees, including High Hazards, Energy and Public Safety, Health and Safety Innovation, Operational Excellence, our General Inspectorate, Specialist Interventions, and Health and Technical Services,” says Wilson. Continue →

Dr James Polston has been announced as Scientific Director at Helius Therapeutics, leaving the United States where he was a leader of research and development at the world’s largest medicinal cannabis company, by revenue Leading both extraction and processing during his tenure at Trulieve Cannabis Corporation, Dr Polston was responsible for major R&D initiatives, extraction, manufacturing, product development, and external scientific research programmes. Continue →

Site Safe New Zealand has announced the appointment of a new Chief Executive Brett Murray has been appointed as the not-for-profit’s new Chief Executive and will take over from outgoing Chief Executive, Alison Molloy, on September 3. Continue →